Skip to content

A Stepped Care Intervention to Reduce Disparities in Mental Health Services Among Cancer Patients and Caregivers

A Stepped-Care Intervention to Reduce Disparities in Mental Health Services Among Underserved Lung and Head and Neck Cancer Patients and Their Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03016403
Enrollment
535
Registered
2017-01-10
Start date
2017-04-03
Completion date
2020-07-17
Last updated
2021-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Head and Neck, Cancer, Lung

Brief summary

Medically under-served (i.e., low-income, uninsured, underinsured) cancer patients generally encounter significant disparities in accessing care for their mental health needs while undergoing toxic treatments that provide considerable physical and emotional stress. Thus, the investigators propose to adapt evidence-based strategies to a stepped-care intervention model to address the mental health needs of under-served lung cancer (LC) and head and neck cancer (HNC) patients and their caregivers across several levels of symptom severity (e.g., mild, moderate, or severe symptoms of depression and anxiety).

Interventions

BEHAVIORALStepped-Care Intervention

The intervention delivered evidence-based CBT and stress management across eight counseling sessions.

BEHAVIORALEnhanced Usual Care

Consists of a list of standard mental health resources offered at the participating hospital, local community, or national non-profit organizations.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. LC and HNC patients: Inclusion Criteria: * Newly diagnosed LC and/or HNC (within a month of recruitment date from the date of 1st visit oncology, Ear Nose and Throat (ENT), or radiation clinic visit/consultation upon pathologic tissue diagnosis; * LC and/or HNC patients at any stage of diagnosis (Stages 0-IV); * Over 18 years old; * English and/or Spanish speaking; * Medically underserved, as defined by at least one or several of the following: 1. Low-income: Below 400% of the 2016 Federal poverty levels; 2. Uninsured: No health insurance (public or private insurance); 3. Underinsured: e.g.: Public insurance (Medicaid, Medicare exclusive, VA); and/or 10% of annual income on out-of-pocket medical expenses for individuals below 200% of the 2016 Federal poverty levels.

Exclusion criteria

* Individuals who do not meet eligibility criteria, including individuals who do not speak English or Spanish; * Those who refuse treatment at one of three hospital sites; * Decisionally-challenged adults with cognitive or personality impairment; * Suicidal ideation, or * Intoxication (alcohol or drugs) that might interfere with their ability to consent or participate in the study; * Individuals from vulnerable populations (e.g., inmates or individuals on probation, * homeless, * pregnant women, and * those with auditory impairment. Note: Individuals who become pregnant or develop auditory impairments after they have been randomized to study condition may remain in the study until completion. 2. Caregivers of LC and/or HNC patients Inclusion Criteria: * Primary caregiver of a newly diagnosed LC and/or HNC patient (per criteria for patients); * Over 18 years old; * English and/or Spanish speaking; * Medically underserved, as defined by at least one or several of the following: 1. Low-income: Below 400% of the 2016 Federal poverty levels; 2. Uninsured: No health insurance (public or private insurance); 3. Underinsured: * (c.1) Public insurance (i.e., Medicaid, Medicare exclusive, VA); * (c.2) 10% of annual income spent on out-of-pocket medical expenses for individuals below 200% of the 2016 Federal poverty level.

Design outcomes

Primary

MeasureTime frameDescription
Symptoms of Depression-Patients6-monthsPatient-Reported Outcomes Measurement Information System (PROMIS)-Cancer (CA) Form v1.0 - Depression (30 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses.
Symptoms of Anxiety-Patients6-monthsPatient-Reported Outcomes Measurement Information System, Anxiety (PROMIS-Ca) Form v1.0- Anxiety (22 items). The range of scores is between 8 and 40. The raw scores were used. Higher score corresponds to worse outcome.
Change in Coping-Patients6-monthsCoping Self-Efficacy (26 items). Scores can rage from 0 to 260. Higher score corresponds to better outcome.

Secondary

MeasureTime frameDescription
Health-Related Quality of Life-Patients6-monthsFACT-G version 4 (27 items). The range is 0-108. Higher values indicate better QOL.
Perceived Stress-Patients6-monthsPerceived Stress Scale (PSS) (14 items). The range of scores is 0-40. Higher values indicate higher stress.
Change in Coping-Caregivers6-monthsCoping Self-Efficacy (26 items). Higher score corresponds to better outcome. Scores can rage from 0 to 260. The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.
Caregiving Burden-Caregivers6-monthsZarit Burden Interview (ZBI) (12 items). The range of scores is 0-48. Higher scores represent higher burden.
Perceived Stress-Caregivers6-monthsPerceived Stress Scale (PSS) (14 items). The range is from 0 to 40. Higher values indicate higher stress.
Symptoms of Anxiety-Caregivers6-monthsPROMIS Form v1.0 - Anxiety (29 items). The range of scores is from 8 to 40. Higher score indicates worse outcome (higher anxiety). Raw scores were used in analyses. The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.
Symptoms of Depression-Caregivers6-monthsPROMIS Form v1.0 - Depression (28 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses. The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.

Countries

United States

Participant flow

Recruitment details

Both patients and caregivers were recruited for this study. Primary outcomes data were focused on patients. Caregiver data were included as secondary analyses.

Participants by arm

ArmCount
Patients in Enhanced Usual Care
Patients who were randomized to Enhanced Usual Care
139
Patients in Stepped Care Intervention
Patients who were randomized to the Stepped Care Intervention
147
Caregivers in Enhanced Usual Care
Caregivers who were randomized to Enhanced Usual Care
118
Caregivers in Stepped Care Intervention
Caregivers who were randomized to the Stepped Care Intervention
131
Total535

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
3-month Follow-up and 6-month Follow-upDeath6400
3-month Follow-up and 6-month Follow-upLost to Follow-up6786
3-month Follow-up and 6-month Follow-upWithdrawal by Subject0001
6-week Follow-upDeath1400
6-week Follow-upLost to Follow-up2748
6-week Follow-upWithdrawal by Subject0201
BaselineDeath5810
BaselineLost to Follow-up911624
BaselineWithdrawal by Subject28410

Baseline characteristics

CharacteristicPatients in Enhanced Usual CareTotalCaregivers in Stepped Care InterventionCaregivers in Enhanced Usual CarePatients in Stepped Care Intervention
Age, Customized
18 to 65
65 Participants267 Participants69 Participants64 Participants69 Participants
Age, Customized
Above 65
74 Participants221 Participants36 Participants33 Participants78 Participants
Age, Customized
Under 18
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Customized
Unknown or Not Report
0 Participants47 Participants26 Participants21 Participants0 Participants
Cancer Stage
Stage 0, I, & II
65 Participants132 Participants0 Participants0 Participants67 Participants
Cancer Stage
Stage III & IV
73 Participants151 Participants0 Participants0 Participants78 Participants
Cancer Stage
Unknown or Not Reported
1 Participants3 Participants0 Participants0 Participants2 Participants
Diagnosis
Head and neck cancer
60 Participants120 Participants0 Participants0 Participants60 Participants
Diagnosis
Lung cancer
79 Participants166 Participants0 Participants0 Participants87 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
27 Participants126 Participants37 Participants28 Participants34 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
112 Participants408 Participants94 Participants89 Participants113 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants0 Participants1 Participants0 Participants
Language Preference
English
133 Participants494 Participants118 Participants111 Participants132 Participants
Language Preference
Spanish
6 Participants41 Participants13 Participants7 Participants15 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants8 Participants3 Participants1 Participants3 Participants
Race (NIH/OMB)
Asian
1 Participants13 Participants5 Participants6 Participants1 Participants
Race (NIH/OMB)
Black or African American
6 Participants25 Participants7 Participants3 Participants9 Participants
Race (NIH/OMB)
More than one race
2 Participants7 Participants2 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants4 Participants0 Participants3 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants27 Participants7 Participants4 Participants11 Participants
Race (NIH/OMB)
White
123 Participants451 Participants107 Participants99 Participants122 Participants
Region of Enrollment
United States
139 participants286 participants131 participants118 participants147 participants
Sex: Female, Male
Female
54 Participants310 Participants99 Participants92 Participants65 Participants
Sex: Female, Male
Male
85 Participants225 Participants32 Participants26 Participants82 Participants
Step at Baseline
Step 1 & 2
106 Participants415 Participants106 Participants89 Participants114 Participants
Step at Baseline
Step 3 & 4
33 Participants119 Participants25 Participants29 Participants32 Participants
Step at Baseline
Unknown or Not Reported
0 Participants1 Participants0 Participants0 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
13 / 13918 / 1471 / 1180 / 131
other
Total, other adverse events
0 / 1390 / 1470 / 1180 / 131
serious
Total, serious adverse events
13 / 13919 / 1471 / 1180 / 131

Outcome results

Primary

Change in Coping-Patients

Coping Self-Efficacy (26 items). Scores can rage from 0 to 260. Higher score corresponds to better outcome.

Time frame: 6-months

Population: Intention to treat population.

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareChange in Coping-Patients190 score on a scaleStandard Deviation 55
Patients in Stepped Care InterventionChange in Coping-Patients207 score on a scaleStandard Deviation 54
Comparison: Linear mixed models (LMM) have been used with time and the interaction between time and group as fixed effects. A structure of random effects that includes random intercepts for patients was used. The study was powered for testing the hypothesis of no group differences in change over the four time points. A significant group by time interaction was hypothesized.p-value: 0.006195% CI: [-26.23, -4.39]Mixed Models Analysis
Primary

Symptoms of Anxiety-Patients

Patient-Reported Outcomes Measurement Information System, Anxiety (PROMIS-Ca) Form v1.0- Anxiety (22 items). The range of scores is between 8 and 40. The raw scores were used. Higher score corresponds to worse outcome.

Time frame: 6-months

Population: Intention to treat population.

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareSymptoms of Anxiety-Patients16.0 score on a scaleStandard Deviation 7
Patients in Stepped Care InterventionSymptoms of Anxiety-Patients13.9 score on a scaleStandard Deviation 6.6
Comparison: Linear mixed models (LMM) have been used with time and the interaction between time and group as fixed effects. A structure of random effects that includes random intercepts for patients was used. The study was powered for testing the hypothesis of no group differences in change over the four time points. A significant group by time interaction was hypothesized.p-value: 0.024395% CI: [0.19, 2.73]Mixed Models Analysis
Primary

Symptoms of Depression-Patients

Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer (CA) Form v1.0 - Depression (30 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses.

Time frame: 6-months

Population: Intention to treat population- all participants who were randomized were included in this analysis. The reported means correspond to the observed means at 6 months.

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareSymptoms of Depression-Patients15.3 score on a scaleStandard Deviation 7
Patients in Stepped Care InterventionSymptoms of Depression-Patients13.2 score on a scaleStandard Deviation 5.7
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.005795% CI: [0.52, 2.98]Mixed Models Analysis
Secondary

Caregiving Burden-Caregivers

Zarit Burden Interview (ZBI) (12 items). The range of scores is 0-48. Higher scores represent higher burden.

Time frame: 6-months

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareCaregiving Burden-Caregivers13 score on a scaleStandard Deviation 9
Patients in Stepped Care InterventionCaregiving Burden-Caregivers9 score on a scaleStandard Deviation 8
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.004495% CI: [0.8, 4.32]Mixed Models Analysis
Secondary

Change in Coping-Caregivers

Coping Self-Efficacy (26 items). Higher score corresponds to better outcome. Scores can rage from 0 to 260. The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.

Time frame: 6-months

Population: Intention to treat population.

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareChange in Coping-Caregivers192 score on a scaleStandard Deviation 52
Patients in Stepped Care InterventionChange in Coping-Caregivers211 score on a scaleStandard Deviation 50
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.2195% CI: [-19.73, 4.27]Mixed Models Analysis
Secondary

Health-Related Quality of Life-Patients

FACT-G version 4 (27 items). The range is 0-108. Higher values indicate better QOL.

Time frame: 6-months

Population: Intention to treat population.

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareHealth-Related Quality of Life-Patients73 score on a scaleStandard Deviation 19
Patients in Stepped Care InterventionHealth-Related Quality of Life-Patients80 score on a scaleStandard Deviation 19
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.013495% CI: [-7.45, -0.87]Mixed Models Analysis
Secondary

Perceived Stress-Caregivers

Perceived Stress Scale (PSS) (14 items). The range is from 0 to 40. Higher values indicate higher stress.

Time frame: 6-months

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CarePerceived Stress-Caregivers15 score on a scaleStandard Deviation 7
Patients in Stepped Care InterventionPerceived Stress-Caregivers11 score on a scaleStandard Deviation 7
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.026995% CI: [0.2, 3.34]Mixed Models Analysis
Secondary

Perceived Stress-Patients

Perceived Stress Scale (PSS) (14 items). The range of scores is 0-40. Higher values indicate higher stress.

Time frame: 6-months

Population: intention to treat population

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CarePerceived Stress-Patients14 score on a scaleStandard Deviation 7
Patients in Stepped Care InterventionPerceived Stress-Patients13 score on a scaleStandard Deviation 7
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.4295% CI: [-0.9, 2.12]Mixed Models Analysis
Secondary

Symptoms of Anxiety-Caregivers

PROMIS Form v1.0 - Anxiety (29 items). The range of scores is from 8 to 40. Higher score indicates worse outcome (higher anxiety). Raw scores were used in analyses. The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.

Time frame: 6-months

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareSymptoms of Anxiety-Caregivers17 score on a scaleStandard Deviation 7
Patients in Stepped Care InterventionSymptoms of Anxiety-Caregivers14 score on a scaleStandard Deviation 7
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.05295% CI: [-0.01, 3.05]Mixed Models Analysis
Secondary

Symptoms of Depression-Caregivers

PROMIS Form v1.0 - Depression (28 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses. The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.

Time frame: 6-months

ArmMeasureValue (MEAN)Dispersion
Patients in Enhanced Usual CareSymptoms of Depression-Caregivers15.0 score on a scaleStandard Deviation 6.9
Patients in Stepped Care InterventionSymptoms of Depression-Caregivers13.2 score on a scaleStandard Deviation 5.7
Comparison: A linear mixed model (LMM) with random intercepts for both patients and clinics has been used, with adjustment for cancer type and cancer stage. The study was powered for testing the hypothesis of no group differences in change over the four time points (baseline, 6-weeks, 3-months and 6-months). A significant group by time interaction was hypothesized.p-value: 0.21495% CI: [-0.52, 2.36]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026